跳至主要内容
临床试验/ACTRN12617000332325
ACTRN12617000332325已完成未知

An evaluation to investigate the impact of the New Medicine Support Service on adherence to newly prescribed medicines

PS MedicineWise0 个研究点目标入组 847 人开始时间: 2017年3月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
847

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • To be included in the study patients must meet the following criteria:
  • * Be aged 18 years or above;
  • * Be a Medicare and/or Department of Veterans affairs (DVA) card holder;
  • * Be living at home in a community setting;
  • * Be on a newly prescribed medicine for one of the following conditions:
  • –Asthma and other lung conditions such as COPD
  • –Conditions requiring antiplatelet / anticoagulant therapy
  • –Depression
  • –Dyslipidaemia
  • –Hypertension
  • –Type 2 diabetes
  • * Be able to understand and willing to consent to the study.

排除标准

  • -Patient cannot communicate sufficiently in English.
  • -Patients of public or private hospitals, day hospital facilities, transitional care facilities or to residents of an Aged Care facility.
  • - Patients who are collecting medicine where the only change from the previous medicine involves a dosage, strength, brand or formulation change(s).

研究者

发起方
PS MedicineWise

相似试验